MB
Mihir Bakul Kapadia
About Mihir Bakul Kapadia
Mihir Bakul Kapadia has 18 years in corporate governance. Holds Managing Director and Director roles. Currently with 4 companies, including Noble Medicals Private Limited and Noble Medichem Private Limited. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Noble Medicals Private Limited
U52300MH2013PTC243723
|
Managing Director | 28 May 2013 | 2013 | Active |
Noble Medichem Private Limited
U24100MH1992PTC069250
|
Director | 29 Aug 2007 | 1992 | Active |
|
Noble Plus Online Private Limited
U74999MH2021PTC358544
|
Director | 08 Apr 2021 | 2021 | Active |
|
Noble Essential Services Llp
ABA-9131
|
Designated Partner | 08 Mar 2024 | 2022 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
|
Zain Distributors Private Limited
U74900MH2016PTC274465
|
Director | 16 Mar 2016 | 2016 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mihir Bakul Kapadia
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mihir Bakul Kapadia
Mihir Bakul Kapadia has 18 years in corporate governance. Holds Managing Director and Director roles. Currently with 4 companies, including Noble Medicals Private Limited and Noble Medichem Private Limited. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.
Mihir Bakul Kapadia is associated with 4 companies as Managing Director and Director.
Mihir Bakul Kapadia has expertise in General Business.
Mihir Bakul Kapadia has 18 years in corporate governance.